NeoGenomics, Inc. (NASDAQ:NEO) Stock Holdings Lessened by BNP Paribas Financial Markets
BNP Paribas Financial Markets trimmed its position in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 49.3% during the 4th quarter, HoldingsChannel reports. The firm owned 36,984 shares of the medical research company’s stock after selling 35,979 shares during the quarter. BNP Paribas Financial Markets’ holdings in NeoGenomics were worth $609,000 at the end […]
BNP Paribas Financial Markets trimmed its position in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 49.3% during the 4th quarter, HoldingsChannel reports. The firm owned 36,984 shares of the medical research company’s stock after selling 35,979 shares during the quarter. BNP Paribas Financial Markets’ holdings in NeoGenomics were worth $609,000 at the end […]
